Multistate operator’s cannabis delivery partnership convinces executives to expand

October 25, 2023 · MJ Biz Daily

When Massachusetts-based multistate operator MariMed decided to launch a delivery service in its home state two years ago, company executives started studying other cannabis carrier services to become experts on the subject.

They considered launching a distribution service from scratch and also looked at acquiring a delivery company in Massachusetts before deciding to invest in Little Dog Delivery.

The state had granted a social equity delivery license to Sebastian Pollack, a senior production manufacturing administrator at MariMed, and the two businesses decided to create a strategic partnership.

According to U.S. Securities and Exchange Commission filings, Pollack owns 51% of the company and MariMed owns 49%.

MariMed’s hope for the partnership was for Little Dog to be an extension of Panacea Wellness, the three retail stores MariMed operates in eastern Massachusetts.

Today, Little Dog has three delivery vans – one operating out of each Panacea Wellness store – and does business as Panacea Delivery Powered by Little Dog.

“We want customers to understand that it’s an extension of Panacea and give credit to the underlying service,” said Ryan Crandall, chief revenue officer at MariMed.

The vans deliver within a 25-mile radius of MariMed’s three stores, which allows them to cover eastern Massachusetts from the New Hampshire border to Cape Cod. The delivery fee of $10 is waived for orders of more than $200.

Costs of operating the delivery business include outfitting and maintaining the vehicles.

For example, Massachusetts requires cannabis delivery vehicles to have GPS and a cage that separates the marijuana products in the back from the driver in front. The state also requires that the driver be accompanied by a second employee in the passenger seat.

Has the investment been worth it?

“We’re still seeing, every month, transactions go up. … We see the delivery consumer as a high-value consumer,” Crandall said. “Typically, the average order value is higher for the delivery consumer.

“We also believe that they’re a pretty sticky consumer, and we believe that if we provide a high level of service to these folks that we’re going to potentially create a stickier consumer than somebody who comes into the retail store.”

To promote the delivery business, MariMed partnered with yoga studios and other local businesses, providing them with discount codes to share with their own employees.

Keys to success in marijuana delivery include being on time, providing good communication, discounts and loyalty points, Crandall said.

The Massachusetts experiment went well enough that MariMed launched delivery in Delaware, another market where it operates.

Unlike in Massachusetts, MariMed launched the Delaware delivery service from scratch as part of its existing medical retail model rather than partnering with or investing in an existing delivery business. Delaware lawmakers legalized recreational marijuana earlier this year.

Crandall said that while MariMed tries to keep standard operating procedures (SOPs) between the delivery services similar – each dispensary in Delaware also has one vehicle that delivers within a 25-mile radius – there are some differences.

For example, Delaware requires only one employee per delivery vehicle rather than a driver and second person, as Massachusetts does.

MariMed doesn’t yet have delivery in Illinois, the third state in which it operates. Crandall believes MariMed will eventually offer delivery for Illinois consumers, and he wants to be ready when that happens.

“We have created a delivery organization within retail and have subject matter experts for delivery” who are tasked with studying regulations, implementing timelines and gauging profitability, Crandall said.

“We look at all of those things and then decide whether or not it makes sense for delivery in a given state,” he said.

“I think it’s going to be a growing piece of the cannabis business.” (Full Story)

Next Post

Oregon Cannabis Industry Groups Merge Amid Market Downturn

Two cannabis industry groups in Oregon have decided to join forces in a merger that comes amid a downturn in the state’s market for legal marijuana. The two groups, the Oregon Cannabis Association and the Cannabis Industry Alliance of Oregon,…
Previous Post

Missouri marijuana operators face fresh turmoil amid recall confusion

Missouri marijuana executives are hoping to return to some sense of normalcy after the state’s $1 billion-plus cannabis market underwent whiplash last week over the status of 62,000 infused products recalled from store shelves back in August. The back-and-forth began…
Random Post

Biden’s cannabis pardons didn’t free a single federal prisoner or deliver the expungement he promised

Edwin Rubis has served more than two decades of a 40-year federal prison sentence for participating in a marijuana distribution operation. Taking into account “good time” credit, he is not scheduled to be released until August 2032. Rubis is one of about…
Random Post

Florida Marijuana Initiative Will ‘Improve Quality Of Life’ By Providing Alcohol Alternative, Top Cannabis CEO Says, Pushing Back Against DeSantis

If Florida voters approve a marijuana legalization initiative at the ballot, that could actually “improve quality of life” for residents—in contrast with the governor’s recent comments to the contrary—the CEO of a multi-state cannabis operator that has financially supported the…
Random Post

RI House OKs bill to legalize ‘magic mushrooms’ statewide

Rhode Island is one step closer to decriminalizing so-called “magic mushrooms” statewide. The House approved legislation Monday that would allow Rhode Islanders to possess up to one ounce of psilocybin or grow magic mushrooms at home for personal use. It would also,…
Random Post

Australia Legalizes Psilocybin And MDMA Prescriptions As U.S. Patients Seek Similar Authorization

The Australian government has rescheduled the psychedelics psilocybin and MDMA to provide access to people with post-traumatic stress disorder (PTSD) and treat-resistant depression. The substances aren’t being legalized for broad use, but by placing them in Schedule 8 for therapeutic…